1219130-55-8 Usage
General Description
2-pyridinone-8-boronic ester is a chemical compound that contains a boronic ester group attached to a pyridinone ring. 2-pyridinone-8-boronic ester is commonly used in organic synthesis as a building block for the construction of various organic molecules. Boronic esters are known for their ability to undergo diverse chemical transformations, and the presence of the pyridinone ring enhances the reactivity and selectivity of the compound. 2-pyridinone-8-boronic ester has found applications in the development of pharmaceuticals, agrochemicals, and materials science due to its versatile reactivity and potential for introducing functional groups into organic molecules. 2-pyridinone-8-boronic ester is of interest to researchers and chemists seeking to create new and valuable chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1219130-55-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,1,3 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1219130-55:
(9*1)+(8*2)+(7*1)+(6*9)+(5*1)+(4*3)+(3*0)+(2*5)+(1*5)=118
118 % 10 = 8
So 1219130-55-8 is a valid CAS Registry Number.
1219130-55-8Relevant articles and documents
5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS
-
Page/Page column 75, (2021/02/12)
The present invention relates to novel aminopyridine derivatives of the general formula (I) and pharmaceutical compositions comprising these compounds, as well as their therapeutic use, particularly as neuropeptide FF (NPFF) receptor antagonists, including, e.g., for the treatment or prevention of pain, opioid-induced hyperalgesia, or addiction.
HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR COMPRISING SAME AS ACTIVE INGREDIENT
-
Page/Page column 31, (2011/08/04)
Novel heterocyclic biaryl derivatives were disclosed which are useful as pharmaceutical agents and which exhibit a phosphodiesterase-inhibitory action. The heterocyclic biaryl derivatives are represented by the following general formula (1): wherein the H